CHAMPIONS ONCOLOGY, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Champions Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Champions Oncology, Inc. Return On Equity for the quarter ending July 31, 2024 was 326 %.
  • Champions Oncology, Inc. annual Return On Equity for 2023 was -97.8 %, a 55.6% decline from 2022.
  • Champions Oncology, Inc. annual Return On Equity for 2022 was -62.9 %, a 901% decline from 2021.
  • Champions Oncology, Inc. annual Return On Equity for 2021 was 7.85 %, a 21.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -97.8 -34.9 -55.6% May 1, 2023 Apr 30, 2024
2022 -62.9 -70.7 -901% May 1, 2022 Apr 30, 2023
2021 7.85 -2.17 -21.7% May 1, 2021 Apr 30, 2022
2020 10 +129 May 1, 2020 Apr 30, 2021
2019 -119 -131 -1058% May 1, 2019 Apr 30, 2020
2018 12.4 +79.3 May 1, 2018 Apr 30, 2019
2017 -66.9 +153 +69.6% May 1, 2017 Apr 30, 2018
2016 -220 +1.45K +86.8% May 1, 2016 Apr 30, 2017
2015 -1.67K -2K -608% May 1, 2015 Apr 30, 2016
2014 329 +230 +232% May 1, 2014 Apr 30, 2015
2013 99.3 -111 -52.8% May 1, 2013 Apr 30, 2014
2012 210 May 1, 2012 Apr 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.